Stock comparison
AbbVie Inc. is 226.9x more valuable than ANAPTYSBIO, INC by market capitalization ($438.31 B vs $1.93 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ABBV is larger
AbbVie Inc. is 226.9x more valuable than ANAPTYSBIO, INC by market capitalization ($438.31 B vs $1.93 B).
Market value leader
ABBV
AbbVie Inc. is 226.9x more valuable than ANAPTYSBIO, INC by market capitalization ($438.31 B vs $1.93 B).
Revenue leader
ABBV
ANAB: $234.60M vs ABBV: $61.16B.
Profit leader
ABBV
ANAB: -$13.23M vs ABBV: $4.23B.
Margin leader
ABBV
ANAB: -5.6% vs ABBV: 6.9% net margin.
| Metric | ANAB | ABBV |
|---|---|---|
| Market cap | $1.93 B | $438.31 B |
| US-listed rank | #2164 | #26 |
| Revenue (latest FY) | $234.60M | $61.16B |
| Net income (latest FY) | -$13.23M | $4.23B |
| Net margin | -5.6% | 6.9% |
| P/E (trailing FY) | - | 103.7x |
| SEC filings | 678 | 1,008 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AbbVie Inc. is 226.9x more valuable than ANAPTYSBIO, INC by market capitalization ($438.31 B vs $1.93 B).
In their latest fiscal years, ANAPTYSBIO, INC reported $234.60M in revenue while AbbVie Inc. reported $61.16B.
Full pages: ANAPTYSBIO, INC and AbbVie Inc., or browse the full rankings.